Association of the inflammatory potential of diet and lower urinary tract symptoms among men in the United States

References

• Coyne KS, Sexton CC, Thompson CL, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009;104(3):352–360.
   PubMed Web of Science ®Google Scholar
• De Nunzio C, Tubaro A. Unmet needs in managing LUTS—a European perspective. Nat Rev Urol. 2012;9(1):9–10.
   Web of Science ®Google Scholar
• Fourcade RO, Lacoin F, Rouprêt M, et al. Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. World J Urol. 2012;30(3):419–426.
   PubMed Web of Science ®Google Scholar
• Parsons JK. Benign prostatic hyperplasia and male Lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010;5(4):212–218.
   PubMedGoogle Scholar
• Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 2006;48(4):677–685.
   PubMed Web of Science ®Google Scholar
• Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440–1446.
   PubMed Web of Science ®Google Scholar
• Liao X, Tang Z, Ai J, et al. Detection of prostatic inflammation from peripheral lymphocyte count and free/total PSA ratio in men With LUTS/BPH. Front Pharmacol. 2020;11:589–589.
   PubMed Web of Science ®Google Scholar
• Cantu H, Maarof SNM, Hashim H. The inflammatory contracted bladder. Curr Bladder Dysfunct Rep. 2019;14(2):67–74.
   Web of Science ®Google Scholar
• Lai J, Ge M, Shen S, et al. Activation of NFKB-JMJD3 signaling promotes bladder fibrosis via boosting bladder smooth muscle cell proliferation and collagen accumulation. Biochim Biophys Acta Mol Basis Dis. 2019;1865(9):2403–2410.
   PubMed Web of Science ®Google Scholar
• Cavicchia PP, Steck SE, Hurley TG, et al. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr. 2009;139(12):2365–2372.
   PubMed Web of Science ®Google Scholar
• Shivappa N, Steck SE, Hurley TG, et al. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17(8):1689–1696.
   PubMed Web of Science ®Google Scholar
• Tabung FK, Steck SE, Zhang J, et al. Construct validation of the dietary inflammatory index among postmenopausal women. Ann Epidemiol. 2015;25(6):398–405.
   PubMed Web of Science ®Google Scholar
• Shivappa N, Steck SE, Hurley TG, et al. A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS). Public Health Nutr. 2014;17(8):1825–1833.
   PubMed Web of Science ®Google Scholar
• Wirth MD, Shivappa N, Davis L, et al. Construct validation of the dietary inflammatory index among African Americans. J Nutr Health Aging. 2017;21(5):487–491.
   PubMed Web of Science ®Google Scholar
• Garcia-Arellano A, Martínez-González MA, Ramallal R, et al. Dietary inflammatory index and all-cause mortality in large cohorts: the SUN and PREDIMED studies. Clin Nutr. 2019;38(3):1221–1231.
   PubMed Web of Science ®Google Scholar
• Park YM, Choi MK, Lee SS, et al. Dietary inflammatory potential and risk of mortality in metabolically healthy and unhealthy phenotypes among overweight and obese adults. Clin Nutr. 2019;38(2):682–688.
   PubMed Web of Science ®Google Scholar
• Resciniti NV, Lohman MC, Wirth MD, et al. Dietary inflammatory index, pre-frailty and frailty among older US adults: evidence from the National Health and Nutrition Examination Survey, 2007–2014. J Nutr Health Aging. 2019;23(4):323–329.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li Q, Xu X. Dietary inflammatory index and the risk of prostate cancer: a dose-response meta-analysis. Eur J Clin Nutr. 2020;74(7):1001–1008.
   PubMed Web of Science ®Google Scholar
• Shivappa N, Hébert JR, Rosato V, et al. Dietary inflammatory index and risk of bladder cancer in a large Italian case-control study. Urology. 2017;100:84–89.
   PubMed Web of Science ®Google Scholar
• Ahluwalia N, Dwyer J, Terry A, et al. Update on NHANES dietary data: focus on collection, release, analytical considerations, and uses to inform public policy. Adv Nutr. 2016;7(1):121–134.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Fantus RJ, Packiam VT, Wang CH, et al. The relationship between sleep disorders and lower urinary tract symptoms: results from the NHANES. J Urol. 2018;200(1):161–166.
   PubMed Web of Science ®Google Scholar
• Hussein MR, Al-Assiri M, Musalam AO. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma. Exp Mol Pathol. 2009;86(2):108–113.
   PubMed Web of Science ®Google Scholar
• Robert G, Descazeaud A, Nicolaiew N, et al. Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis. Prostate. 2009;69(16):1774–1780.
   PubMed Web of Science ®Google Scholar
• Vital P, Castro P, Tsang S, et al. The senescence-associated secretory phenotype promotes benign prostatic hyperplasia. Am J Pathol. 2014;184(3):721–731.
   PubMed Web of Science ®Google Scholar
• Kramer G, Steiner GE, Handisurya A, et al. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate. 2002;52(1):43–58.
   PubMed Web of Science ®Google Scholar
• Steiner GE, Stix U, Handisurya A, et al. Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest. 2003;83(8):1131–1146.
   PubMed Web of Science ®Google Scholar
• Hamakawa T, Sasaki S, Shibata Y, et al. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells. Prostate. 2014;74(6):590–601.
   PubMedGoogle Scholar
• Briganti A, Capitanio U, Suardi N, et al. Benign prostatic hyperplasia and Its aetiologies. Eur Urol Suppl. 2009;8(13):865–871.
   Web of Science ®Google Scholar
• De Nunzio C, Aronson W, Freedland SJ, et al. The correlation between metabolic syndrome and prostatic diseases. Eur Urol. 2012;61(3):560–570.
   PubMed Web of Science ®Google Scholar
• De Nunzio C, Kramer G, Marberger M, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol. 2011;60(1):106–117.
   PubMed Web of Science ®Google Scholar
• Alcaraz A, Hammerer P, Tubaro A, et al. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol. 2009;55(4):864–873.
   PubMed Web of Science ®Google Scholar
• Schenk JM, Kristal AR, Neuhouser ML, et al. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol. 2010;171(5):571–582.
   PubMed Web of Science ®Google Scholar
• Lagiou P, Wuu J, Trichopoulou A, et al. Diet and benign prostatic hyperplasia: a study in Greece. Urology. 1999;54(2):284–290.
   PubMed Web of Science ®Google Scholar
• Bravi F, Bosetti C, Dal Maso L, et al. Food groups and risk of benign prostatic hyperplasia. Urology. 2006;67(1):73–79.
   PubMed Web of Science ®Google Scholar
• Cox LAT. Jr. Risk analysis implications of dose-response thresholds for NLRP3 inflammasome-mediated diseases: respirable crystalline silica and lung cancer as an example. Dose Response. 2019;17(2):155932581983690.
   Web of Science ®Google Scholar
• Scherer A, Noest A, de Boer RJ. Activation-threshold tuning in an affinity model for the T-cell repertoire. Proc R Soc Lond B. 2004;271(1539):609–616.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Mikami N, Wing JB, et al. Regulatory T cells and human disease. Annu Rev Immunol. 2020;38:541–566.
   PubMed Web of Science ®Google Scholar